Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Hadron Therapy Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hadron Therapy Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Electron Beam
      • 1.3.3 Proton Beam
      • 1.3.4 Neutron Beam
      • 1.3.5 Carbon Ion Beam
      • 1.3.6 Alpha Particle Beam
      • 1.3.7 Beta Particle Beam
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hadron Therapy Market Share by Application (2019-2025)
      • 1.4.2 Pediatric Cancer
      • 1.4.3 Bone and Soft Tissue Cancer
      • 1.4.4 Prostate Cancer
      • 1.4.5 Lung Cancer
      • 1.4.6 Liver Cancer
      • 1.4.7 Eye Cancer
      • 1.4.8 Head & Neck Cancer
      • 1.4.9 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Hadron Therapy Production Value 2014-2025
      • 2.1.2 Global Hadron Therapy Production 2014-2025
      • 2.1.3 Global Hadron Therapy Capacity 2014-2025
      • 2.1.4 Global Hadron Therapy Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Hadron Therapy Market Size CAGR of Key Regions
      • 2.2.2 Global Hadron Therapy Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Hadron Therapy Capacity by Manufacturers
      • 3.1.2 Global Hadron Therapy Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hadron Therapy Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hadron Therapy Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hadron Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hadron Therapy Price by Manufacturers
    • 3.4 Key Manufacturers Hadron Therapy Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hadron Therapy Market
    • 3.6 Key Manufacturers Hadron Therapy Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Electron Beam Production and Production Value (2014-2019)
      • 4.1.2 Proton Beam Production and Production Value (2014-2019)
      • 4.1.3 Neutron Beam Production and Production Value (2014-2019)
      • 4.1.4 Carbon Ion Beam Production and Production Value (2014-2019)
      • 4.1.5 Alpha Particle Beam Production and Production Value (2014-2019)
      • 4.1.6 Beta Particle Beam Production and Production Value (2014-2019)
    • 4.2 Global Hadron Therapy Production Market Share by Type
    • 4.3 Global Hadron Therapy Production Value Market Share by Type
    • 4.4 Hadron Therapy Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hadron Therapy Consumption by Application

    6 Production by Regions

    • 6.1 Global Hadron Therapy Production (History Data) by Regions 2014-2019
    • 6.2 Global Hadron Therapy Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Hadron Therapy Production Growth Rate 2014-2019
      • 6.3.2 United States Hadron Therapy Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Hadron Therapy Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Hadron Therapy Production Growth Rate 2014-2019
      • 6.4.2 European Union Hadron Therapy Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Hadron Therapy Import & Export
    • 6.5 China
      • 6.5.1 China Hadron Therapy Production Growth Rate 2014-2019
      • 6.5.2 China Hadron Therapy Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Hadron Therapy Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Hadron Therapy Consumption by Regions

    • 7.1 Global Hadron Therapy Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Hadron Therapy Consumption by Type
      • 7.2.2 United States Hadron Therapy Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Hadron Therapy Consumption by Type
      • 7.3.2 European Union Hadron Therapy Consumption by Application
    • 7.4 China
      • 7.4.1 China Hadron Therapy Consumption by Type
      • 7.4.2 China Hadron Therapy Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Hadron Therapy Consumption by Type
      • 7.5.2 Rest of World Hadron Therapy Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Koninklijke Philips N.V.
      • 8.1.1 Koninklijke Philips N.V. Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Hadron Therapy
      • 8.1.4 Hadron Therapy Product Introduction
      • 8.1.5 Koninklijke Philips N.V. Recent Development
    • 8.2 Advanced Oncotherapy
      • 8.2.1 Advanced Oncotherapy Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Hadron Therapy
      • 8.2.4 Hadron Therapy Product Introduction
      • 8.2.5 Advanced Oncotherapy Recent Development
    • 8.3 Varian Medical Systems
      • 8.3.1 Varian Medical Systems Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Hadron Therapy
      • 8.3.4 Hadron Therapy Product Introduction
      • 8.3.5 Varian Medical Systems Recent Development
    • 8.4 Optivus Proton Therapy
      • 8.4.1 Optivus Proton Therapy Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Hadron Therapy
      • 8.4.4 Hadron Therapy Product Introduction
      • 8.4.5 Optivus Proton Therapy Recent Development
    • 8.5 Hitachi, Ltd.
      • 8.5.1 Hitachi, Ltd. Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Hadron Therapy
      • 8.5.4 Hadron Therapy Product Introduction
      • 8.5.5 Hitachi, Ltd. Recent Development
    • 8.6 Mevion Medical Systems
      • 8.6.1 Mevion Medical Systems Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Hadron Therapy
      • 8.6.4 Hadron Therapy Product Introduction
      • 8.6.5 Mevion Medical Systems Recent Development
    • 8.7 ProTom International
      • 8.7.1 ProTom International Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Hadron Therapy
      • 8.7.4 Hadron Therapy Product Introduction
      • 8.7.5 ProTom International Recent Development
    • 8.8 Mitsubishi Electric Corporation
      • 8.8.1 Mitsubishi Electric Corporation Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Hadron Therapy
      • 8.8.4 Hadron Therapy Product Introduction
      • 8.8.5 Mitsubishi Electric Corporation Recent Development
    • 8.9 Sumitomo Corporation
      • 8.9.1 Sumitomo Corporation Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Hadron Therapy
      • 8.9.4 Hadron Therapy Product Introduction
      • 8.9.5 Sumitomo Corporation Recent Development
    • 8.10 ProNova Solutions, LLC
      • 8.10.1 ProNova Solutions, LLC Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Hadron Therapy
      • 8.10.4 Hadron Therapy Product Introduction
      • 8.10.5 ProNova Solutions, LLC Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Hadron Therapy Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Hadron Therapy Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Hadron Therapy Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Hadron Therapy Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Hadron Therapy Production Forecast by Type
      • 9.7.2 Global Hadron Therapy Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Hadron Therapy Sales Channels
      • 10.2.2 Hadron Therapy Distributors
    • 10.3 Hadron Therapy Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
      When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
      The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
      In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
      In 2019, the market size of Hadron Therapy is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hadron Therapy.

      This report studies the global market size of Hadron Therapy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Hadron Therapy production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Koninklijke Philips N.V.
      Advanced Oncotherapy
      Varian Medical Systems
      Optivus Proton Therapy
      Hitachi, Ltd.
      Mevion Medical Systems
      ProTom International
      Mitsubishi Electric Corporation
      Sumitomo Corporation
      ProNova Solutions, LLC

      Market Segment by Product Type
      Electron Beam
      Proton Beam
      Neutron Beam
      Carbon Ion Beam
      Alpha Particle Beam
      Beta Particle Beam

      Market Segment by Application
      Pediatric Cancer
      Bone and Soft Tissue Cancer
      Prostate Cancer
      Lung Cancer
      Liver Cancer
      Eye Cancer
      Head & Neck Cancer
      Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Hadron Therapy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Hadron Therapy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Hadron Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now